11.2 Capital

In physics, 11.2 km/s is the escape velocity from Earth's gravity. We invest in founders solving the biggest challenges facing our world with emerging technologies. We focus on emerging technologies such as AI, cybersecurity, robotics, quantum, new space, computational therapeutics, synthetic biology. ​We believe great people are leading indicators of a company's success. 11.2 Capital’s technical background, operational experience, and a strong network of amazing advisors and international partners particularly in Asia deliver a unique set of resources to entrepreneurs. While we are happy to help companies across the full range of early-stage company questions, areas where we concentrate include technical recruiting, partnerships (OEM and distribution partnerships for smart hardware companies, data partnerships for data-driven healthcare companies), customer introductions (CISO introductions for security companies, provider introductions for healthcare companies), and follow-on financings. We aspire to be one of the most helpful investors to a company and help create something extraordinary.

David Dorsey

Partner

38 past transactions

Orbital Sidekick, Inc.

Funding Round in 2021
Orbital Sidekick, Inc. provides Earth observation and analysis services, using hyperspectral imaging technology. The company offers small satellite constellation of hyperspectral capability. It captures narrow contiguous spectral bands, from visible light through infrared. The company caters to energy, oil and gas, mining, environmental monitoring, infrastructure, agriculture, and defense sectors. Orbital Sidekick, Inc. was founded in 2016 and is based in San Francisco, California.

Hinge Health

Series D in 2021
Hinge Health is pioneering digital care programs for people with chronic musculoskeletal conditions such as back or joint pain. Founded by Oxford and Cambridge scientists, thay've empowered thousands to conquer chronic pain, avoid unnecessary surgeries, and liberate them to do the things they love. Founded in 2014, the company is headquartered in San Francisco, California.

Matchwell LLC

Venture Round in 2020
Matchwell LLC operates an online marketplace that matches clinicians with healthcare facilities. The company allow clinicians to join the facility pools they want to work in, see available shift information, and directly communicate with facility hiring managers if needed. Matchwell LLC was incorporated in 2017 and is based in Durham, North Carolina.

Notable Labs, Inc.

Series B in 2019
Notable Labs, Inc. develops and operates a platform that provides lab testing services for brain cancer patients. The company runs drug combination experiments on the tumor and gives a report back to the patient’s doctor. Notable Labs, Inc. was formerly known as StemCycle, Inc. The company was incorporated in 2014 and is based in Foster City, California.

Sardine

Seed Round in 2021
FinTech, RegTech, Fraud Operating System

Savioke

Convertible Note in 2015
Savioke develops and deploys autonomous robots that work in human environments to improve people’s lives. The company’s flagship product, Relay, is a beautifully simple yet sophisticated delivery robot that increases productivity, revenue, and delight for people across a range of markets, industries, and applications. Relay is the first delivery robot that works autonomously alongside people in busy environments such as hotels, high rise residential, industrial, and healthcare. Founded in 2013 by a team of leading robotics engineers, Savioke is backed by investors such Intel Capital, EDBI, Northern Light Venture Capital, Morado Venture Partners, AME Cloud Ventures, Recruit Partners, and Google Ventures. For more information, visit www.savioke.com.

CryptoNumerics Inc.

Seed Round in 2019
HIPAA, GDPR and Data Residency requirements restrict your ability to conduct data science. CryptoNumerics removes these restrictions. CryptoNumerics enables you to create privacy protected datasets with quantifiable privacy risk. In addition, you can build statistical and machine learning models that protect people’s privacy. Our team consists of engineers and visionaries with previous experience in C-Level roles at Fortune 500 companies, founding teams of venture backed growth stage start-ups, and accomplished R&D leaders.

Auransa Inc.

Series A in 2020
Auransa is an AI-driven platform for discovering drugs of novel pharmacology from vast amounts of genomics data collected from human disease tissues. The company's platform is used to study molecular disease subtypes and predict compounds and targets for responder patient population. Current internal drug pipeline includes cancer and other diseases. The company has partnership with companies and institutions in biopharma industry.

Outlier

Series A in 2018
Outlier AI, Inc. operates an automated business analysis platform that provides insights based on data for consumer, financial services, and life sciences organizations globally. It offers Outlier, an analytical solution that enable businesses to make decisions; and monitors the business data and notifies when unexpected changes occur. The company serves consumer packaged goods, ecommerce and retail, and pharmaceutical industries. Outlier AI, Inc. was founded in 2015 and is based in Oakland, California.

GraphSQL

Seed Round in 2013
TigerGraph is a provider of a graph database platform for enterprise applications. It fulfills the true promise and benefits of the graph platform by supporting real-time deep link analytics for enterprises with complex and colossal amounts of data. TigerGraph’s proven technology is used by customers including Alipay, VISA, SoftBank, State Grid Corporation of China, Wish and Elementum. The company supports applications such as IoT, AI, and machine learning to make sense of ever-changing big data. It also provides personalized recommendations, fraud prevention, supply-chain logistics, company knowledge graph, and other features. Founded by Yu Xu, Ph.D. in 2012, TigerGraph is funded by Qiming VC, Baidu, Ant Financial, AME Cloud, Morado Ventures, Zod Nazem, Danhua Capital, and DCVC. TigerGraph is based in Redwood City, CA.

Deep Genomics Inc.

Seed Round in 2015
Deep Genomics Inc., an artificial intelligence (AI) therapeutics company, develops individualized genetic medicines by creating AI systems that are used to accelerate various steps of drug discovery and development, including target discovery, lead optimization, toxicity assessment, and innovative trial design. It develops and markets therapies for rare metabolic, ophthalmologic, and neurodegenerative disorders. The company develops oligonucleotide therapies that target the genetic determinants of disease at the level of RNA or DNA. Deep Genomics Inc. was founded in 2014 and is based in Toronto, Canada.

Nanocore

Series A in 2018
Nanocore is an engineering company that engages in 3D metal printing technology to produce high resolution parts that meet the critical needs of applications from automotive and aerospace to consumer product design and prototyping. NanoCore is bringing to market the first metal 3D printer that is within the budget of companies of all sizes.

Passage AI

Seed Round in 2017
Passage AI is a venture-backed company located in the heart of Silicon Valley. We were founded in 2016 by three Silicon Valley veterans with an extensive background in deep learning and artificial intelligence. We are funded by leading seed/angel investors. Our mission is to make it seamless for businesses to converse with their customers, and help businesses put their customers first. Passage AI's platform provides the AI, NLU/P, and deep learning technology as well as the bot building tools to create and deploy a conversational interface for your business.

Nanocore

Series B in 2021
Nanocore is an engineering company that engages in 3D metal printing technology to produce high resolution parts that meet the critical needs of applications from automotive and aerospace to consumer product design and prototyping. NanoCore is bringing to market the first metal 3D printer that is within the budget of companies of all sizes.

Notable Labs, Inc.

Series B in 2019
Notable Labs, Inc. develops and operates a platform that provides lab testing services for brain cancer patients. The company runs drug combination experiments on the tumor and gives a report back to the patient’s doctor. Notable Labs, Inc. was formerly known as StemCycle, Inc. The company was incorporated in 2014 and is based in Foster City, California.

Passage AI

Series A in 2018
Passage AI is a venture-backed company located in the heart of Silicon Valley. We were founded in 2016 by three Silicon Valley veterans with an extensive background in deep learning and artificial intelligence. We are funded by leading seed/angel investors. Our mission is to make it seamless for businesses to converse with their customers, and help businesses put their customers first. Passage AI's platform provides the AI, NLU/P, and deep learning technology as well as the bot building tools to create and deploy a conversational interface for your business.

Loop Genomics

Venture Round in 2016
Loop Genomics is a platform technology for long-read DNA sequencing. Loop Genomics technology transforms short-read DNA sequencers into high-throughput, long-read, single-molecule DNA sequencing machines. Loop Genomics long-read DNA sequencing technology provides phased sequencing solutions across a diverse repertoire of research and clinical applications. Sequencing of partial rRNA gene sequences results in reduced phylogenetic resolution. Full-length, high-throughput, phased sequencing that covers all 16S variable regions is becoming the gold standard for profiling the microbiome. Achieve the highest resolution microbial community profiling with long-read, next-generation sequencing of the microbiome. Characterizing polymorphisms in HLA genes inside and outside of the protein-coding regions is important for organ transplantation compatibility testing and for strengthening causality association studies. The length of homologous sequences between HLA alleles extends beyond the capabilities of short-read sequencing platforms, resulting in diploid ambiguities and a reliance on imputation. Sequence full-length HLA DNA and/or RNA with phased, high throughput, long-read sequencing that resolves allelic discrimination and diploid ambiguity. Viral genetic variability is a major determinant of viral drug resistance and viral vaccine efficacy. Accurately mapping viral genetic variability is a critical step in choosing the optimal course of therapy and developing efficacious vaccines. Key mutations are typically located throughout long stretches of viral genomes, making the retrieval of critical phased data challenging using short-read sequencing technology. Use phased, high-throughput DNA sequencing technology to map key mutations at the quasi-species level and generate a complete phased map of viral populations.

Kindred AI

Series A in 2015
Kindred Systems, Inc. designs and develops artificial intelligence (AI) based robots to solve human problems. Its products include Kindred SORT, an AI powered robotic putwall solution that works with fulfillment center associates to assemble e-commerce orders from batch-picked items; and AutoGrasp, a robotic platform that controls robots to operate with human-like intelligence in dynamic environments. The company was founded in 2014 and is based in San Francisco, California with additional offices in Vancouver and Toronto, Canada.

covariant.ai

Seed Round in 2017
Covariant is a developer of artificial intelligence for robotics. Covariant is building the Covariant Brain, a universal AI to give robots the ability to see, reason and act on the world around them.

Hinge Health

Series C in 2020
Hinge Health is pioneering digital care programs for people with chronic musculoskeletal conditions such as back or joint pain. Founded by Oxford and Cambridge scientists, thay've empowered thousands to conquer chronic pain, avoid unnecessary surgeries, and liberate them to do the things they love. Founded in 2014, the company is headquartered in San Francisco, California.

Bay Labs, Inc.

Seed Round in 2015
Caption Health will use this funding to scale up its commercial operations, continue to develop its AI technology platform and form new partnerships. As more providers adopt the Caption AI platform, the company plans to add new clinical capabilities to expand the use of Caption AI in additional care settings.

Elucidate GmbH

Seed Round in 2020
Elucidate GmbH develops a financial crime risk management platform. Its platform Elucidate FinCrime Index (EFI) uses probabilistic modeling and machine learning and determines financial crime risk for financial institutions. Elucidate GmbH was founded in 2019 and is based in Berlin, Germany.

Forter

Series B in 2014
Forter is an NYC-based company that delivers real-time, completely automated, fraud prevention solutions for online merchants. It creates a completely fraud-free environment for the retailers through which they have the ability to make decisions that are solely based on what is good for their business. The company’s system is designed to be consumer-centric, blocking fraud with accuracy, and at the same time enabling growth by increasing approvals and ensuring a better customer experience.

Umedeor Ltd

Seed Round in 2020
uMed is a technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries. This enables sites to participate in dozens of programmes simultaneously without increasing overhead or burden on staff. For life science companies, uMed provides access to regulator quality data, where patients within those datasets can be compliantly re-engaged to support the aims of R&D and post-market teams

Placenote

Seed Round in 2015
Placenote develops augmented reality-based online platform and mobile application for visual mapping. The company's sticky notepad platform allows people organize and share information through virtual sticky notes attached to objects and physical spaces. It allows users to scan any physical space for turning it into a 3D map marker. The company was founded in 2015 and is based in San Francisco, California with an additional office in Toronto, Canada.

Outlier

Series B in 2020
Outlier AI, Inc. operates an automated business analysis platform that provides insights based on data for consumer, financial services, and life sciences organizations globally. It offers Outlier, an analytical solution that enable businesses to make decisions; and monitors the business data and notifies when unexpected changes occur. The company serves consumer packaged goods, ecommerce and retail, and pharmaceutical industries. Outlier AI, Inc. was founded in 2015 and is based in Oakland, California.

Molecular Assemblies

Seed Round in 2016
Molecular Assemblies, Inc. develops an enzymatic DNA synthesis technology for DNA-based products. Its technology enables the reading and writing of DNA for various industries. The company serves life sciences, industrial, information storage, nanotechnology, and DNA electronics markets. Molecular Assemblies, Inc. was founded in 2013 and is based in San Diego, California.

Diassess

Series A in 2015
Lucira Health develops a new class of professional and home-health solutions to help illuminate and elucidate health status to expedite decision-making and treatment. The company's at-home test kit is well suited for home use and the molecular nucleic acid amplification technology is adaptable to COVID-19 detection. Lucira Health produces inexpensive, disposable health diagnostic hardware that transforms any smartphone into a portable, real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids anywhere in the world. It enables consumers to take the first step in their healthcare management through at-home diagnosis and a companion mobile app to provide follow up treatment. Lucira Health was founded in 2013 and is headquartered in Emeryville, California, United States.

Hinge Health

Series A in 2017
Hinge Health is pioneering digital care programs for people with chronic musculoskeletal conditions such as back or joint pain. Founded by Oxford and Cambridge scientists, thay've empowered thousands to conquer chronic pain, avoid unnecessary surgeries, and liberate them to do the things they love. Founded in 2014, the company is headquartered in San Francisco, California.

Cruise Automation

Convertible Note in 2014
Cruise is building the world’s most advanced self-driving vehicles to safely connect people with the places, things, and experiences they care about. Cruise autonomous vehicles are on the road in San Francisco navigating some of the most challenging and unpredictable driving environments, because the best way to bring self-driving technology to the world is to expose it to the same unique and complex traffic scenarios human drivers face every day.

Anyscale, Inc.

Series A in 2019
Anyscale, Inc. develops and operates distributed programming platforms and tools for simplifying distributed AI development. It offers development and commercialization of Ray. It enables software developers and machine learning engineers to scale their applications. Anyscale, Inc. was formerly known as Indigostack, Inc. and changed its name to Anyscale, Inc. in November 2019. The company was incorporated in 2019 and is based in Berkeley, California.

Synthace Limited

Series A in 2017
Synthace's goal is to raise universal bioscience productivity, enabling people to better engineer biology for health, food, energy and manufacturing. Central to its technology is Antha, an operating system for biology that enables ease of designing and optimizing biological unit operations that are linked into executable workflows that are reliable, shareable and saleable. Antha spreads biological information in a repeatable way, linking lab equipment, protocols and processes, thereby allowing vast and speedy development, enhancing productivity for any bioscience.

Hinge Health

Seed Round in 2016
Hinge Health is pioneering digital care programs for people with chronic musculoskeletal conditions such as back or joint pain. Founded by Oxford and Cambridge scientists, thay've empowered thousands to conquer chronic pain, avoid unnecessary surgeries, and liberate them to do the things they love. Founded in 2014, the company is headquartered in San Francisco, California.

Ginkgo Bioworks

Series B in 2015
Ginkgo Bioworks, Inc. designs, engineers, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. The company also provides probiotic bacteria to protect the body from dangerous infections; and generates libraries of molecules. It serves cultured ingredients, carbon mitigation, probiotics, and natural product discovery markets. Ginkgo Bioworks, Inc. was founded in 2008 and is based in Boston, Massachusetts.

White Ops, Inc.

Convertible Note in 2014
HUMAN is a cybersecurity company that protects enterprises from bot attacks to keep digital experiences human. We have the most advanced Human Verification Engine that protects applications, APIs and digital media from bot attacks, preventing losses and improving the digital experience for real humans. Today we verify the humanity of more than 10 trillion interactions per week for some of the largest companies and internet platforms. Protect your digital business with HUMAN. To Know Who’s Real, visit www.humansecurity.com.